Nasdaq Q4 Earnings: In "Outstanding" 2025, Nasdaq Exceeds $5 Billion in Net Revenue for the First Time

Nasdaq reported record 2025 results with net revenues of $5.2 billion, a 13% year-over-year increase, and non-GAAP diluted EPS up 24% for the year (27% in Q4). Solutions revenue exceeded $4 billion, Market Services net revenue reached $1.2 billion, Q4 net revenue was $1.4 billion, index revenue was $232 million (up 23%) with year-end AUM of $882 billion and $99 billion of net inflows; Financial Technology revenue was $498 million in Q4 (up 12%) and cross-sell momentum continued post‑Adenza. Management highlighted AI integration across products, record listings activity including a $1.2 trillion transfer (Walmart), launches in tokenized securities and plans for 23/5 trading, signaling continued platform-driven growth and strategic initiatives likely to influence investor positioning.

Analysis

Market structure: Nasdaq’s $5.2B revenue and >$4B Solutions run-rate amplify exchange/fintech winner-take-share dynamics — exchanges with integrated SaaS/indices capabilities capture higher recurring revenue and pricing power. Direct beneficiaries: NDAQ, index-linked ETF issuers, enterprise fintech vendors (Verafin/Adenza stack); losers: smaller exchanges, legacy niche market-technology providers and trading venues that compete on price rather than integrated services. Higher IPO/activity (72% IPO win rate, $1.2T transfer) signals sustained supply of new equity issuance and ETF product demand, supporting fee pools for at least 12–24 months.

Risk assessment: Key tail risks include SEC pushback on tokenized securities or market-structure changes (litigation/withdrawals) and a major operational outage or AI-data breach that could hit reputation and client retention; probability low but P&L impact high. Near-term catalysts: Investor Day Feb 25 (30 days) and H2 2026 23/5 rollout; hidden dependency is execution risk integrating Adenza/Verafin at scale and client concentration among G‑SIBs which can shift renewal dynamics quickly.

Trade implications: Tactical: bias long NDAQ into Feb 25 and through H2 2026 implementation — revenue growth and margin expansion appear durable; express via equity and calibrated options. Relative-value: long NDAQ vs short ICE (ICE) to play Nasdaq’s listing/cross-sell momentum. Options: buy-call spreads into Feb 25 (small notional) and into H2 2026 catalyst window to cap premium while retaining upside.

Key Decisions for Investors

• Initiate a 3% long position in NDAQ over the next 10 trading days (scale in 50%/50%), target +20% upside over 12 months, hard stop-loss at -10% and trim at +15%; rationale: recurring Solutions revenue growth and listing momentum ahead of Feb 25 Investor Day and H2 2026 23/5 rollout.
• Establish a relative-value pair: long NDAQ 2% vs short ICE 1.5% (ratio ~1.33:1) for 6–12 months to capture Nasdaq’s listing/technology premium; exit if NDAQ/ICE price ratio moves adverse by 8% or if Nasdaq volumes decline >15% QoQ.
• Buy a small, event-driven call spread: Mar-2026 (30–45 day) NDAQ ATM call buy / +15% strike sell sized 0.5% of portfolio into Feb 25 Investor Day; take profits at +50% option return or cut at -60% to limit premium loss.
• Defer any incremental exposure tied to tokenized-securities execution until receipt of SEC clearance or absence of adverse comment letters; monitor SEC filings/comments over next 30–60 days — if cleared, add incremental 1–2% NDAQ within 10 trading days of approval.